{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260617408304/en/FDA-Approves-Pfizer%E2%80%99s-IBRANCE-Regimen-for-HR-HER2-Metastatic-Breast-Cancer-Frontline-Maintenance", "message": "News view counter 814674 successfully enlarged"}